Woodline Partners LP Celldex Therapeutics, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,014,015 shares of CLDX stock, worth $46.4 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,014,015
Previous 2,341,121
13.97%
Holding current value
$46.4 Million
Previous $79.5 Million
36.0%
% of portfolio
0.38%
Previous 0.72%
Shares
11 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$207 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$117 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$89.5 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$86.5 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.08B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...